Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00911079 · ClinicalTrials.gov registry record · NA
Pilot Study of a Catheter-based Ultrasound Hyperthermia System
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00911079 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 13 participants.
The verdict
NCT00911079, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
RATIONALE: Hyperthermia therapy kills tumor cells by heating them to several degrees above normal body temperature. Ultrasound energy may be able to kill tumor cells by heating up the tumor cells without affecting the surrounding tissue. Implant radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving ultrasound hyperthermia therapy after implant radiation therapy may kill more tumor cells. PURPOSE: This clinical trial is studying ultrasound hyperthermia therapy to see how well it works after implant radiation therapy in treating patients with Stage III/IV cancer of the cervix or prostate cancer with a rising prostate specific antigen (PSA) after prior local therapy.
Interventions
- RADIATION HDR brachytherapy
- PROCEDURE Hyperthermia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-12-18 |
| Est. Completion | 2020-07-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00911079
The ClinicalTrials.gov registry entry for NCT00911079 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HDR brachytherapy is the first listed.
NCT00911079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00911079 about?
NCT00911079 is a clinical study titled "Pilot Study of a Catheter-based Ultrasound Hyperthermia System". RATIONALE: Hyperthermia therapy kills tumor cells by heating them to several degrees above normal body temperature. Ultrasound energy may be able to kill tumor cells by heating up the tumor cells without affecting the surrounding tissue. Implant radiation therapy uses radioactive material placed dir...
What is the current status of trial NCT00911079?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2009-12-18. Estimated completion is 2020-07-23.
What interventions are being tested in trial NCT00911079?
The interventions under investigation include: HDR brachytherapy (RADIATION), Hyperthermia (PROCEDURE).
Who is sponsoring clinical trial NCT00911079?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.